Original language | English |
---|---|
Pages (from-to) | 1631-1634 |
Number of pages | 4 |
Journal | Bone Marrow Transplantation |
Volume | 59 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2024 |
Externally published | Yes |
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT
Urban Novak, Jarl E. Mooyaart, Michael Daskalakis, Christof Scheid, Ludovic Gabellier, Ibrahim Yakoub-Agha, Ron Ram, Edouard Forcade, Lucía López-Corral, Emma Nicholson, Eugenio Galli, Friedrich Stölzel, Wolfgang Bethge, Eva Maria Wagner-Drouet, Jorinde D. Hoogenboom, Stephan Mielke, Caroline Arber, Federico Simonetta, Christian Chabannon, Jürgen Kuball
*Corresponding author for this work
- University of Bern
- EBMT Statistics
- University of Cologne
- GMM-UMR5535-CNRS
- CHU de Lille
- Tel Aviv Sourasky Medical Center
- Hôpital du Haut-Lévêque
- Hospital Clínico Universitario de Salamanca
- Royal Marsden NHS Foundation Trust
- Catholic University of the Sacred Heart
- University Medical Center Schleswig- Holstein
- University of Tübingen
- Johannes Gutenberg University Mainz
- EBMT Leiden Study Unit
- Karolinska Institutet
- University of Lausanne
- Service d’Hématologie
- Aix-Marseille Université
- Utrecht University
- IRCCS San Raffaele Scientific Institute
- Sorbonne Université
Research output: Contribution to journal › Letter › peer-review
1
Scopus
citations